Search

Author/Creator Sundy, J.

2. FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study. (23rd January 2014)

Authors:
Perez-Ruiz, F.; Sundy, J.; Krishnan, E.; Hingorani, V.; Welp, J.; Rodgers, T.; Manhard, K.; Cravets, M.; Hagerty, D.; Quart, B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS. (2nd June 2020)

Authors:
Westhovens, R.; Rigby, W.; Van der Heijde, D.; Ching, D.; Stohl, W.; Kay, J.; Chopra, A.; Bartok, B.; Matzkies, F.; Yin, Z.; Guo, Y.; Tasset, C.; Sundy, J.; Jahreis, A.; Mozaffarian, N.; Messina, O.; Landewé, R. B. M.; Atsumi, T.; Burmester, G. R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
1019
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS. (2nd June 2020)

Authors:
Combe, B.; Kivitz, A.; Tanaka, Y.; Van der Heijde, D.; Simon-Campos, J. A.; Baraf, H. S. B.; Kumar, U.; Matzkies, F.; Bartok, B.; Ye, L.; Guo, Y.; Tasset, C.; Sundy, J.; Jahreis, A.; Mozaffarian, N.; Landewé, R. B. M.; Bae, S. C.; Keystone, E.; Nash, P.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search